Nasal potential difference in congenital bilateral absence of the vas deferens

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 896-901

  Pradal, Ugo ^a,b   Castellani, Carlo ^a   Delmarco, Antonella ^a   Mastella, Gianni ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b Cystic Fibrosis Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACTION POTENTIAL; ADULT; AGENESIS; ARTICLE; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; MALE GENITAL TRACT MALFORMATION; MEMBRANE TRANSPORT; NOSE MUCOSA; PRIORITY JOURNAL; SODIUM TRANSPORT; VAS DEFERENS;

EID: 0031721049     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9711029     Document Type: Article

References (31)

1. Jequier, A. M., I. D. Ansell, and N. J. Bullimore. 1985. Congenital absence of the vasa deferentia presenting with infertility. J. Androl. 6: 15-21.
2. Patrizio, P., and J. Zielenski. 1996. Congenital absence of the vas deferens: a mild form of cystic fibrosis. Mol. Med. Today 24-31.
3. Anguiano, A., R. D. Oates, J. A. Amos, M. Dean, B. Gerrard, C. Stewart, T. A. Maner, M. B. White, and A. Milunsky. 1992. Congenital absence of the vas deferens: a primarily genital form of cystic fibrosis. J.A.M.A. 267:1794-1797.
4. Dumur, V., R. Gervais, J. Rigot, E. Delomel-Vinner, B. Decaestecker, J. Lafitte, and P. Russel. 1996. Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype. Hum. Genet. 97:7-10.
5. Buocher, R. C. 1994. Human airway ion transport (Part Two). Am. J. Respir. Crit. Care Med. 150:581-593.
6. Knowles, M. R., J. L. Carson, A. M. Collier, J. T. Gatzy, and R. C. Boucher. 1981. Measurement of nasal transepithelial electric potential difference in normal human subjects in vivo. Am. Rev. Respir. Dis. 124:484-490.
7. Knowles, M. R., A. M. Paradiso, and R. C. Boucher. 1995. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther. 6:445-455.
8. Middleton, P. G., D. M. Geddes, and E. W. F. W. Alton. 1994. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur. Respir. J. 7:2050-2056.
9. Alton, E. W. F. W., D. Currie, R. Logan-Sinclair, J. O. Warner, M. E. Hodson, and D. M. Geddes. 1990. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur. Respir. J. 3:922-926
10. Sauder, R.A., S. E. Chesrow, and G. M. Loughlin. 1987. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J. Pediatr. 111:353-358.
11. Hofman, T., O. Böhmen, G. Hüls, H. G. Tebrack, P. Bittner, V. Klingmüller, E. Heerd, and H. Lindemann. 1997. Conventional and modified nasal potential difference measurement in cystic fibrosis. Am. J. Respir. Crit. Care Med. 155:1908-1913.
12. Knowles, M. R., K. Honheker, Z. Zhou, J. C. Olsen, T. L. Noah, P. Hu, M. W. Leigh, J. Engelhardt, L. J. Edwards, K. R. Jones, M. Grossman, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1995. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333:823-831.
13. Welsh, M., A. E. Smith, J. Zabner, D. P. Rich, S. M. Graham, R. J. Gregory, B. M. Pratt, and R. A. Moscicki. 1994. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5:209-219.
14. Delmarco, A., U. Pradal, G. Cabrini, A. Bonizzato, and G. Mastella. 1997. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur. Respir. J. 10:1145-1149.
15. Cystic Fibrosis Foundation. 1996. The diagnosis of cystic fibrosis: consensus statement, Vol. 7, Section I. 1-15.
16. Osborne, L. R., M. Lynch, P. G. Middleton, E. W. F. W. Alton, D. M. Geddes, J. P. Pryor, M. E. Hodson, and G. K. Santis. 1993. Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum. Mol. Genet. 2:1605-1609.
17. Stern, R. C. 1997. The diagnosis of cystic fibrosis. N. Engl. J. Med. 7:487-491.
18. Gibson, L. E., and R. E. Cooke. 1959. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pylocarpine by iontophoresis. Pediatrics 23:544-549.
19. Chehab, F. F., and J. Wall. 1992. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum. Genet. 89:163-168.
20. Chillon, M., T. Casals, B. Mercier, L. Bassas, W. Lissens, S. Silber, M. Romey, J. Ruiz-Romero, C. Verlingue, M. Claustres, V. Nunes, C. Ferec, and X. Estivill. 1995. Mutations in the cystic fibrosis gene in patients with congenital absens of the vas deferens. N. Engl. J. Med. 332:1475-1480.
21. Davis, P., M. Drumm, and M. W. Konstan. 1996. State of the art: cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
22. Mercier, B., C. Verlingue, W. Lissens, S. J. Silber, G. Novelli, M. Bonduelle, M. P. Audrézet, and C. Férec. 1995. Is congenital absence of the vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am. J. Hum. Genet. 56:272-277.
23. Casals, T., L. Bassas, J. Ruiz-Romero, M. Chillon, J. Giménez, M. D. Ramos, G. Tapia, H. Narvaez, V. Nunes, and X. Estivill. 1995. Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected. Hum. Genet. 95:205-211.
24. Colin, A. A., S. M. Sawyer, J. E. Mickle, R. D. Oates, A. Milunsky, and J. A. Amos. 1996. Pulmonary function and clinical observations in men with congenital bilateral absence of the vas deferens. Chest 110: 440-445.
25. Alton, E. W. F. W., J. G. Hay, C. Munro, and D. M. Geddes. 1987. Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome and bronchiectasis. Thorax 42:815-817.
26. Strong, T. V., L. S. Smit, S. v. Turpin, J. L. Cole, C. Tom Hon, D. Markiewicz, T. L. Petty, M. W. Craig, E. C. Rosenow, L. Tsui, M. C. Iannuzzi, M. R. Knowles, and F. S. Collins. 1991. Cystic fibrosis gene mutation in two sisters with mild disease and normal electrolyte levels. N. Engl. J. Med. 325:1630-1634.
27. Highsmith, W. E., L. H. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittell, K. J. Friedman, L. M. Silverman, R. C. Boucher, and M. R. Knowles. 1994. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat electrolyte concentrations. N. Engl. J. Med. 331:974-980.
28. Stewart, B., J. Zabner, A. P. Shuber, M. J. Welsh, and P. B. McCray. 1995. Normal sweat chloride levels do not exclude the diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:899-903.
29. Knowles, M., J. Gatzy, and R. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305:1489-1495.
30. Labbè, A., G. Bellon, M. C. Hèraud, P. Arbre, G. Goddon, and E. Alton. 1991. Détermination des différences de potentiel transépithélial (DDPTE) nasal dans la mucoviscidose. Arch Fr. Pediatr. 48:617-620.
31. Charfi, M. R., R. Matran, J. Regnard, and A. Lockhart. 1996. Mesure de la différence de potentiel transépithélial nasal: un test diagnostique de la mucoviscidose. Rev. Pneumol. Clin. 52:9-13.